1. Home
  2. AEHL vs MOLN Comparison

AEHL vs MOLN Comparison

Compare AEHL & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Antelope Enterprise Holdings Limited

AEHL

Antelope Enterprise Holdings Limited

N/A

Current Price

$10.25

Market Cap

126.4M

Sector

Industrials

ML Signal

N/A

Logo Molecular Partners AG

MOLN

Molecular Partners AG

N/A

Current Price

$3.01

Market Cap

137.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AEHL
MOLN
Founded
1993
2004
Country
China
Switzerland
Employees
N/A
N/A
Industry
Building Materials
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
126.4M
137.2M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
AEHL
MOLN
Price
$10.25
$3.01
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $10.22
AVG Volume (30 Days)
★ 1.5M
1.8K
Earning Date
07-06-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$3.09
52 Week High
$30.60
$5.36

Technical Indicators

Market Signals
Indicator
AEHL
MOLN
Relative Strength Index (RSI) 51.66 31.61
Support Level $0.83 N/A
Resistance Level $16.79 $4.21
Average True Range (ATR) 1.95 0.11
MACD 0.25 -0.04
Stochastic Oscillator 31.56 1.23

Price Performance

Historical Comparison
AEHL
MOLN

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in three reportable operating segments: Business Management Consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting; Natural Gas Power generation, which was in the initial development stage; and Live-Streaming e-commerce segment, providing a one-stop solution for customers to enable them to utilize the growing sales channel of livestreaming ecommerce. The business of the Company is engaged in the PRC and the United States.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Share on Social Networks: